Eur J Neurosci 12:14311439 Mueller SG, Trabesinger AH, Boesiger P, Wieser HG (2001) Brain glutathione levels in patients with epilepsy measured by in vivo (1)H-MRS
Safety and Precautionary Guidance Although BPC-157 is generally well-tolerated in anecdotal reports, users should be cautious and monitor their responses
Research continues for identifying molecular triggers and environmental factors that could predict the risk of developing diseases such as AD, PD, HD, ALS, Multiple Sclerosis (MS), epilepsy and others
Scientists tested six different CMA formulations in 70 healthy subjects using NAD+ precursors with serine, L-carnitine tartrate (LCAT), and N-acetyl-L-cysteine (NAC) in a double-blinded, placebo-controlled study
Neurological autoimmune diseases (NAD) NAD are characterized by inappropriate immune responses, including the presence of autoantibodies targeting self-antigens in the central nervous system and peripheral nervous system, leading to abnormal immune reactions and the occurrence of NAD
Cancer Biomark
